GSK plc Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2016-04-12: Form 6-K; Period of report 2016-04-12; Description DIRECTOR/PDMR SHAREHOLDING; Document gsk201604116k2.htm.
- 2016-04-11: Form 6-K; Period of report 2016-04-11; Description DIRECTOR/PDMR SHAREHOLDING; Document gsk201604116k.htm.
- 2016-04-01: Form 6-K; Period of report 2016-04-01; Description DIRECTOR/PDMR SHAREHOLDING; Document gsk201604016k4.htm.
- 2016-04-01: Form 6-K; Period of report 2016-04-01; Description DIRECTOR/PDMR SHAREHOLDING; Document gsk201604016k3.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2016-04-12 | 6-K | 2016-04-12 | DIRECTOR/PDMR SHAREHOLDING | gsk201604116k2.htm |
| 2016-04-11 | 6-K | 2016-04-11 | DIRECTOR/PDMR SHAREHOLDING | gsk201604116k.htm |
| 2016-04-01 | 6-K | 2016-04-01 | DIRECTOR/PDMR SHAREHOLDING | gsk201604016k4.htm |
| 2016-04-01 | 6-K | 2016-04-01 | DIRECTOR/PDMR SHAREHOLDING | gsk201604016k3.htm |
| 2016-04-01 | 6-K | 2016-04-01 | GSK RECEIVES POSITIVE CHMP OPINION FOR STRIMVELIS | gsk201604016k2.htm |
| 2016-04-01 | 6-K | 2016-04-01 | TOTAL VOTING RIGHTS | gsk201604016k.htm |
| 2016-03-30 | 6-K | 2016-03-31 | DIRECTOR/PDMR SHAREHOLDING | gsk201603306k2.htm |
| 2016-03-30 | 6-K | 2016-03-30 | NOTICE OF AGM | gsk201603306k.htm |
| 2016-03-29 | 6-K | 2016-03-29 | DIRECTOR/PDMR SHAREHOLDING | gsk201603296k1.htm |
| 2016-03-29 | 6-K | 2016-03-29 | MARKETING APPROVAL RECEIVED FOR NUCALA? IN JAPAN | gsk201603296k.htm |
| 2016-03-22 | 6-K | 2016-03-22 | DIRECTOR/PDMR SHAREHOLDING | gsk201603226k.htm |
| 2016-03-21 | 6-K | 2016-03-21 | ANNUAL REPORT 2015 ON FORM 20-F | gsk201603216k.htm |
| 2016-03-18 | 6-K | 2016-03-18 | DIRECTOR/PDMR SHAREHOLDING | gsk201603186k.htm |
| 2016-03-17 | 6-K | 2016-03-17 | VESTRI STUDY RESULTS GSK ADVAIR IN CHILDREN 4-11 | gsk201603176k4.htm |
| 2016-03-17 | 6-K | 2016-03-17 | DIRECTORATE CHANGES | gsk201603176k3.htm |
| 2016-03-17 | 6-K | 2016-03-17 | SIR ANDREW WITTY TO RETIRE FROM GSK IN MARCH 2017 | gsk201603176k2.htm |
| 2016-03-17 | 6-K | 2016-03-17 | PUBLICATION OF 2015 ANNUAL FINANCIAL REPORT | gsk201603176k.htm |
| 2016-03-11 | 6-K | 2016-03-11 | DIRECTOR/PDMR SHAREHOLDING | gsk201603116k.htm |
| 2016-03-10 | 6-K | 2016-03-10 | DIRECTOR/PDMR SHAREHOLDING | gsk201603106k.htm |
| 2016-03-07 | 6-K | 2016-03-07 | DIRECTOR/PDMR SHAREHOLDING | gsk201603076k1.htm |
| 2016-03-07 | 6-K | 2016-03-07 | NEJM RESULTS OF LABA SAFETY STUDY OF ADVAIR DISKUS | gsk201603076k.htm |
| 2016-03-01 | 6-K | 2016-03-01 | DIRECTOR/PDMR SHAREHOLDING | gsk201603016k7.htm |
| 2016-03-01 | 6-K | 2016-03-01 | DIRECTOR/PDMR SHAREHOLDING | gsk201603016k6.htm |
| 2016-03-01 | 6-K | 2016-03-01 | DIRECTOR/PDMR SHAREHOLDING | gsk201603016k5.htm |
| 2016-03-01 | 6-K | 2016-03-01 | DIRECTOR/PDMR SHAREHOLDING | gsk201603016k3.htm |
| 2016-03-01 | 6-K | 2016-03-01 | DIRECTOR/PDMR SHAREHOLDING | gsk201603016k2.htm |
| 2016-03-01 | 6-K | 2016-03-01 | TOTAL VOTING RIGHTS | gsk201603016k.htm |
| 2016-02-25 | 6-K | 2016-02-25 | DIRECTOR/PDMR SHAREHOLDING | gsk201602256k.htm |
| 2016-02-24 | 6-K | 2016-02-24 | PHII HIV PREVENTION STUDY RESULTS CABOTEGRAVIR | gsk201602246k.htm |
| 2016-02-23 | 6-K | 2016-02-23 | PHII DATA ON 2 DRUG LONG-ACTING INJECTABLE FOR HIV | gsk201602236k.htm |
| 2016-02-22 | 6-K | 2016-02-22 | VIIV COMPLETES TRANSACTION TO ACQUIRE BMS ASSETS | gsk201602226k.htm |
| 2016-02-18 | 6-K | 2016-02-18 | DIRECTOR/PDMR SHAREHOLDING | gsk201602186k.htm |
| 2016-02-16 | 6-K/A | 2016-02-16 | DIRECTOR/PDMR SHAREHOLDING - REPLACEMENT | gsk201602166ka1.htm |
| 2016-02-16 | 6-K/A | 2016-02-16 | DIRECTOR/PDMR SHAREHOLDING - REPLACEMENT | gsk201602166ka.htm |
| 2016-02-16 | 6-K | 2016-02-16 | DIRECTOR/PDMR SHAREHOLDING | gsk201602166k1.htm |
| 2016-02-16 | 6-K | 2016-02-16 | DIRECTOR/PDMR SHAREHOLDING | gsk201602166k.htm |
| 2016-02-16 | 6-K | 2016-02-15 | DIRECTOR/PDMR SHAREHOLDING | gsk201602156k3.htm |
| 2016-02-16 | 6-K | 2016-02-15 | DIRECTOR/PDMR SHAREHOLDING | gsk201602156k2.htm |
| 2016-02-16 | 6-K | 2016-02-16 | DIRECTOR/PDMR SHAREHOLDING | gsk201602156k.htm |
| 2016-02-12 | 6-K | 2016-02-12 | DIRECTOR/PDMR SHAREHOLDING | gsk201602126k1.htm |
| 2016-02-12 | 6-K | 2016-02-12 | DIRECTOR/PDMR SHAREHOLDING | gsk201602126k2.htm |
| 2016-02-12 | 6-K | 2016-02-12 | DIRECTOR/PDMR SHAREHOLDING | gsk201602126k.htm |
| 2016-02-10 | 6-K | 2016-02-10 | DIRECTOR/PDMR SHAREHOLDING | gsk201602106k.htm |
| 2016-02-03 | 6-K | 2016-02-03 | FINAL RESULTS | gsk201602036k.htm |
| 2016-02-02 | 6-K | 2016-02-02 | DIRECTOR/PDMR SHAREHOLDING | gsk201602026k.htm |
| 2016-02-01 | 6-K | 2016-02-01 | DIRECTOR/PDMR SHAREHOLDING | gsk201602016k7.htm |
| 2016-02-01 | 6-K | 2016-02-01 | DIRECTOR/PDMR SHAREHOLDING | gsk201602016k6.htm |
| 2016-02-01 | 6-K | 2016-02-01 | DIRECTOR/PDMR SHAREHOLDING | gsk201602016k5.htm |
| 2016-02-01 | 6-K | 2016-02-01 | DIRECTOR/PDMR SHAREHOLDING | gsk201602016k4.htm |
| 2016-02-01 | 6-K | 2016-02-01 | DIRECTOR/PDMR SHAREHOLDING | gsk201602016k3.htm |
| 2016-02-01 | 6-K | 2016-02-01 | DIRECTOR/PDMR SHAREHOLDING | gsk201602016k2.htm |
| 2016-02-01 | 6-K | 2016-02-01 | TOTAL VOTING RIGHTS | gsk201602016k.htm |
| 2016-01-22 | 6-K | 2016-01-22 | DIRECTOR/PDMR SHAREHOLDING | gsk201601226k.htm |
| 2016-01-21 | 6-K | 2016-01-21 | DIRECTOR/PDMR SHAREHOLDING | gsk201601216k2.htm |
| 2016-01-21 | 6-K | 2016-01-21 | DIRECTOR/PDMR SHAREHOLDING | gsk201601216k.htm |
| 2016-01-19 | 6-K | 2016-01-20 | DIRECTOR/PDMR SHAREHOLDING | gsk201601186k.htm |
| 2016-01-19 | 6-K | 2016-01-20 | DIRECTOR/PDMR SHAREHOLDING | gsk201601186k2.htm |
| 2016-01-15 | 6-K | 2016-01-15 | DIRECTOR/PDMR SHAREHOLDING | gsk201601156k.htm |
| 2016-01-13 | 6-K | 2016-01-13 | DIRECTOR/PDMR SHAREHOLDING | gsk201601136k.htm |
| 2016-01-08 | 6-K | 2016-01-08 | DIRECTOR/PDMR SHAREHOLDING | gsk201601086k.htm |
| 2016-01-04 | 6-K | 2016-01-04 | DIRECTOR/PDMR SHAREHOLDING | gsk201601046k3.htm |
| 2016-01-04 | 6-K | 2016-01-04 | DIRECTOR/PDMR SHAREHOLDING | gsk201601046k2.htm |
| 2016-01-04 | 6-K/A | 2016-01-04 | TOTAL VOTING RIGHTS | gsk201601046ka.htm |
| 2016-01-04 | 6-K | 2016-01-04 | TOTAL VOTING RIGHTS | gsk201601046k.htm |